This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03970/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03970/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03970/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03970/identifier/drugbank/
n4http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://linked.opendata.cz/resource/drugbank/drug/DB03970/identifier/chemspider/
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03970
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB03970 n9:DB03970
dcterms:title
(6,7-Dihydro-5h-Cyclopenta[D]Imidazo[2,1-B]Thiazol-2-Yl]-4,7-Dihydro[1,4]Thiazepine-3,6-Dicarboxylic Acid
adms:identifier
n8:447998 n10:46508013 n11:DB03970 n12:WY2 n13:394935
n5:IUPAC-Name
n6:271B5489-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B548F-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B548E-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B548B-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B548C-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B548D-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5487-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5485-363D-11E5-9242-09173F13E4C5 n6:271B5488-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5486-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5495-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5496-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5490-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5491-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5493-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5492-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5494-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B549B-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B549D-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B549E-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B549A-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5499-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B549C-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B548A-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5497-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5498-363D-11E5-9242-09173F13E4C5